[Federal Register Volume 80, Number 41 (Tuesday, March 3, 2015)]
[Notices]
[Pages 11441-11442]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-04330]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices (ACIP)

    Correction: This notice was published in the Federal Register on 
January 30, 2015, Volume 80, Number 20, Page 5116-5117. Due to 
inclement weather in the Atlanta, Georgia area, the first day of the 
meeting scheduled for February 25 and 26, 2015 was not held. The second 
day of the meeting will take place as follows:

[[Page 11442]]

    Times and Dates: 10:00 a.m.-2:00 p.m., February 26, 2015.
    The meeting will be webcast live via the World Wide Web; for 
instructions and more information on ACIP please visit the ACIP Web 
site: http://www.cdc.gov/vaccines/acip/index.html.
    Matters To Be Discussed: The shortened agenda will include 
discussions and votes on: Influenza LAIV use, serogroup B meningococcal 
(MenB) vaccines use in high risk groups, including outbreaks, and the 
use of 9vHPV vaccine.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Stephanie B. Thomas, National 
Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton 
Road NE., MS-A27, Atlanta, Georgia 30333, telephone: (404) 639-8836; 
Email [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both the Centers for Disease Control and Prevention and the Agency for 
Toxic Substances and Disease Registry.

Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2015-04330 Filed 3-2-15; 8:45 am]
BILLING CODE 4163-18-P